Megías-Vericat, J. E., Ballesta-López, O., Barragán, E., & Montesinos, P. (2019). IDH1-mutated relapsed or refractory AML: Current challenges and future prospects. Blood Lymphat Cancer.
Stile di citazione ChicagoMegías-Vericat, Juan Eduardo, Octavio Ballesta-López, Eva Barragán, e Pau Montesinos. "IDH1-mutated Relapsed or Refractory AML: Current Challenges and Future Prospects." Blood Lymphat Cancer 2019.
Citazione MLAMegías-Vericat, Juan Eduardo, Octavio Ballesta-López, Eva Barragán, e Pau Montesinos. "IDH1-mutated Relapsed or Refractory AML: Current Challenges and Future Prospects." Blood Lymphat Cancer 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.